Published in J Exp Med on November 26, 2007
Pyogenic bacterial infections in humans with MyD88 deficiency. Science (2008) 4.92
Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science (2009) 4.45
Dysregulation of germinal centres in autoimmune disease. Nat Rev Immunol (2009) 2.43
T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells. Immunity (2008) 2.03
B cells enhance early innate immune responses during bacterial sepsis. J Exp Med (2011) 1.99
Integration of B cell responses through Toll-like receptors and antigen receptors. Nat Rev Immunol (2012) 1.72
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation. Nat Immunol (2012) 1.70
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. Immunity (2011) 1.70
Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. Blood (2009) 1.64
Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge. Proc Natl Acad Sci U S A (2009) 1.61
Endoplasmic reticulum HSP90b1 (gp96, grp94) optimizes B-cell function via chaperoning integrin and TLR but not immunoglobulin. Blood (2008) 1.55
Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med (2010) 1.54
Toll-like receptors--sentries in the B-cell response. Immunology (2009) 1.52
B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity (2012) 1.47
Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood (2008) 1.42
Toll-like receptor 7 and 9 defects in common variable immunodeficiency. J Allergy Clin Immunol (2009) 1.26
Adjuvant-specific regulation of long-term antibody responses by ZBTB20. J Exp Med (2014) 1.25
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit Rev Immunol (2010) 1.22
Toll-like receptor 7 controls the anti-retroviral germinal center response. PLoS Pathog (2011) 1.16
Requirement for cyclin D3 in germinal center formation and function. Cell Res (2010) 1.16
TLR signaling in B-cell development and activation. Cell Mol Immunol (2012) 1.12
Immunostimulatory activity of haptenated proteins. Proc Natl Acad Sci U S A (2009) 1.10
Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptors. Chembiochem (2009) 1.09
Regulation of B-cell responses by Toll-like receptors. Immunology (2012) 1.07
TLR4 signaling augments B lymphocyte migration and overcomes the restriction that limits access to germinal center dark zones. J Exp Med (2009) 1.04
Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol (2009) 1.04
IRAK-M regulation and function in host defense and immune homeostasis. Infect Dis Rep (2010) 1.03
Endogenous IRAK-M attenuates postinfarction remodeling through effects on macrophages and fibroblasts. Arterioscler Thromb Vasc Biol (2012) 1.02
A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation. Autoimmunity (2010) 1.01
MyD88 plays an essential role in inducing B cells capable of differentiating into antibody-secreting cells after vaccination. J Virol (2011) 1.00
B cell TLRs and induction of immunoglobulin class-switch DNA recombination. Front Biosci (Landmark Ed) (2012) 0.99
Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J Immunol (2009) 0.96
Antigen receptor signals rescue B cells from TLR tolerance. J Immunol (2009) 0.93
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity. J Clin Invest (2015) 0.92
Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors. Mol Med (2012) 0.90
Role of innate immunity in the development of hepatocellular carcinoma. World J Gastroenterol (2013) 0.87
B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice. Blood (2016) 0.85
Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice. J Immunol (2009) 0.85
Lipid motif of a bacterial antigen mediates immune responses via TLR2 signaling. PLoS One (2011) 0.84
Enhanced antibody responses to a detoxified lipopolysaccharide-group B meningococcal outer membrane protein vaccine are due to synergistic engagement of Toll-like receptors. Innate Immun (2009) 0.84
Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front Biosci (Landmark Ed) (2012) 0.83
Maintenance of autoantibody production in pristane-induced murine lupus. Arthritis Res Ther (2015) 0.82
IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice. Diabetes (2014) 0.80
Early activation of teleost B cells in response to rhabdovirus infection. J Virol (2014) 0.80
ProtEx technology for the generation of novel therapeutic cancer vaccines. Exp Mol Pathol (2009) 0.79
Follicular dendritic cell makes environmental sense. Immunity (2010) 0.79
Toll-like receptor function in primary B cell defects. Front Biosci (Elite Ed) (2012) 0.79
Roles of B Cell-Intrinsic TLR Signals in Systemic Lupus Erythematosus. Int J Mol Sci (2015) 0.79
A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression. J Immunol (2012) 0.79
Collagen type II and a thermo-responsive polymer of N-isopropylacrylamide induce arthritis independent of Toll-like receptors: a strong influence by major histocompatibility complex class II and Ncf1 genes. Am J Pathol (2011) 0.78
αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nat Commun (2016) 0.77
TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK. J Exp Med (2017) 0.75
Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis? World J Hepatol (2016) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Toll-like receptor control of the adaptive immune responses. Nat Immunol (2004) 19.15
Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol (2001) 18.80
A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature (1991) 13.19
Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity (1999) 11.64
TLR signaling. Cell Death Differ (2006) 9.24
Maintenance of serological memory by polyclonal activation of human memory B cells. Science (2002) 8.75
Toll-like receptors control activation of adaptive immune responses. Nat Immunol (2001) 7.54
IRAK-M is a negative regulator of Toll-like receptor signaling. Cell (2002) 6.79
Control of B-cell responses by Toll-like receptors. Nature (2005) 6.44
Humoral immunity due to long-lived plasma cells. Immunity (1998) 6.35
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity (2001) 4.92
Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science (2003) 4.80
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
Maintenance of serum antibody levels. Annu Rev Immunol (2005) 3.20
Autoreactivity by design: innate B and T lymphocytes. Nat Rev Immunol (2001) 3.08
Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol (2006) 3.04
Memory B-cell persistence is independent of persisting immunizing antigen. Nature (2000) 2.90
Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation. Int Immunol (2002) 2.66
Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A (1999) 2.63
IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem (1999) 2.43
B cells move to centre stage: novel opportunities for autoimmune disease treatment. Nat Rev Drug Discov (2006) 2.27
TLR9 signaling in B cells determines class switch recombination to IgG2a. J Immunol (2007) 1.95
Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens. J Immunol (2000) 1.72
Immunology: Toll-like receptors and antibody responses. Nature (2006) 1.64
Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood (2002) 1.35
Mycobacterium tuberculosis lipoarabinomannan-mediated IRAK-M induction negatively regulates Toll-like receptor-dependent interleukin-12 p40 production in macrophages. J Biol Chem (2005) 1.29
Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients. Crit Care Med (2006) 1.19
Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med (2006) 0.99
Nitric oxide activates the expression of IRAK-M via the release of TNF-alpha in human monocytes. Nitric Oxide (2004) 0.83
CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity (2010) 5.13
Integration with the human genome of peptide sequences obtained by high-throughput mass spectrometry. Genome Biol (2004) 4.91
Tracking genome engineering outcome at individual DNA breakpoints. Nat Methods (2011) 4.05
Phosphorylation of the CARMA1 linker controls NF-kappaB activation. Immunity (2005) 3.36
Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol (2007) 3.09
HS1 functions as an essential actin-regulatory adaptor protein at the immune synapse. Immunity (2006) 2.23
Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development. Nat Immunol (2007) 2.08
PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling. Nat Immunol (2002) 2.03
BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity (2003) 2.02
WASp-deficient B cells play a critical, cell-intrinsic role in triggering autoimmunity. J Exp Med (2011) 1.91
Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol (2002) 1.77
Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest (2007) 1.77
CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy-treated hemophilia mice. Blood (2009) 1.68
Calcium signalling and cell-fate choice in B cells. Nat Rev Immunol (2007) 1.64
Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma Src homology 2-Src homology 3 linker. J Biol Chem (2004) 1.63
Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation. J Exp Med (2008) 1.55
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. 1993. J Immunol (2012) 1.51
Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J Biol Chem (2004) 1.49
Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORγt and Ahr that leads to IL-17 production by activated B cells. Nat Immunol (2013) 1.38
A disease-associated PTPN22 variant promotes systemic autoimmunity in murine models. J Clin Invest (2013) 1.37
Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood (2008) 1.35
Signaling in transitional type 2 B cells is critical for peripheral B-cell development. Immunol Rev (2004) 1.34
B cell developmental requirement for the G alpha i2 gene. J Immunol (2003) 1.31
Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J Cell Biol (2007) 1.29
Coupling endonucleases with DNA end-processing enzymes to drive gene disruption. Nat Methods (2012) 1.28
Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma. Proc Natl Acad Sci U S A (2002) 1.26
Opposing impact of B cell-intrinsic TLR7 and TLR9 signals on autoantibody repertoire and systemic inflammation. J Immunol (2014) 1.24
Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice. Mol Ther (2004) 1.24
Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol (2011) 1.22
Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI. PLoS One (2011) 1.21
Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice. Blood (2008) 1.17
Protein kinase C family functions in B-cell activation. Curr Opin Immunol (2004) 1.17
A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev (2013) 1.15
Bruton's tyrosine kinase revealed as a negative regulator of Wnt-beta-catenin signaling. Sci Signal (2009) 1.10
B cell autonomous TLR signaling and autoimmunity. Autoimmun Rev (2008) 1.10
Immunomodulation of transgene responses following naked DNA transfer of human factor VIII into hemophilia A mice. Blood (2006) 1.08
B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia. Blood (2010) 1.06
Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright. Mol Cell Biol (2005) 1.06
Development of B-lineage predominant lentiviral vectors for use in genetic therapies for B cell disorders. Mol Ther (2010) 1.04
SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC. Blood (2002) 1.04
Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy. Blood (2009) 1.03
Novel fluorescent genome editing reporters for monitoring DNA repair pathway utilization at endonuclease-induced breaks. Nucleic Acids Res (2013) 1.02
A Ras activation pathway dependent on Syk phosphorylation of protein kinase C. Proc Natl Acad Sci U S A (2003) 1.01
Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription. J Immunol (2009) 1.01
Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome. Blood (2012) 0.99
Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells. Eur J Immunol (2008) 0.99
MAGUK-controlled ubiquitination of CARMA1 modulates lymphocyte NF-kappaB activity. Mol Cell Biol (2009) 0.98
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors. Nucleic Acids Res (2011) 0.96
Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals. J Immunol (2009) 0.96
Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption. Exp Hematol (2009) 0.96
Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. J Allergy Clin Immunol (2010) 0.95
Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease. World J Gastroenterol (2006) 0.95
Serine 649 phosphorylation within the protein kinase C-regulated domain down-regulates CARMA1 activity in lymphocytes. J Immunol (2009) 0.93
Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J Immunol (2009) 0.91
G alpha q-containing G proteins regulate B cell selection and survival and are required to prevent B cell-dependent autoimmunity. J Exp Med (2010) 0.89
Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer. Blood (2004) 0.89
Imatinib suppresses cryoglobulinemia and secondary membranoproliferative glomerulonephritis. J Am Soc Nephrol (2008) 0.88
Low bone mineral density measurements in care home residents--a treatable cause of fractures. Age Ageing (2006) 0.87
CD38 signaling regulates B lymphocyte activation via a phospholipase C (PLC)-gamma 2-independent, protein kinase C, phosphatidylcholine-PLC, and phospholipase D-dependent signaling cascade. J Immunol (2005) 0.87
ATM protein purified from vaccinia virus expression system: DNA binding requirements for kinase activation. Biochem Biophys Res Commun (2004) 0.85
Proximal signals controlling B-cell antigen receptor (BCR) mediated NF-kappaB activation. Adv Exp Med Biol (2006) 0.84
FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. J Immunol (2012) 0.84
Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front Biosci (Landmark Ed) (2012) 0.83
Lifecourse study of bone health at age 49-51 years: the Newcastle thousand families cohort study. J Epidemiol Community Health (2005) 0.83
Immunologic reconstitution during PEG-ADA therapy in an unusual mosaic ADA deficient patient. Clin Immunol (2008) 0.82
Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4. Int Immunol (2012) 0.81
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest (2016) 0.81
Novel reporter systems for facile evaluation of I-SceI-mediated genome editing. Nucleic Acids Res (2011) 0.80
Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells. Eur J Immunol (2012) 0.80
Kinase-independent feedback of the TAK1/TAB1 complex on BCL10 turnover and NF-κB activation. Mol Cell Biol (2013) 0.79
Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation. J Allergy Clin Immunol (2011) 0.79
Cutting edge: regulation of TLR4-driven B cell proliferation by RP105 is not B cell autonomous. J Immunol (2012) 0.78
Emerging roles for PKC isoforms in immune cell function. Mol Interv (2002) 0.77
An exemplum of XLA. Clin Immunol (2007) 0.76
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. J Clin Invest (2016) 0.75